| Income Statement |
| Total Revenue | 808.28M |
|
| Revenues (USD) | 808.28M |
| Cost of Revenue | 413.26M |
| Gross Profit | 395.02M |
| Operating Expenses | 363.51M |
| Research and Development Expense | 170.39M |
| Selling, General and Administrative Expense | 84.03M |
| Operating Income | 31.51M |
| Interest Expense | 17.84M |
| Income Tax Expense | -8.04M |
| Net Income | 29.73M |
| Net Income Common Stock | 29.73M |
| Net Income Common Stock (USD) | 29.73M |
| Consolidated Income | 29.73M |
| Earnings per Basic Share | 0.33 |
| Earnings per Basic Share (USD) | 0.33 |
| Earnings per Diluted Share | 0.32 |
| Earning Before Interest & Taxes (EBIT) | 39.53M |
| Earning Before Interest & Taxes (USD) | 39.53M |
| Weighted Average Shares | 91.89M |
| Weighted Average Shares Diluted | 92.88M |
| Balance Sheet |
| Cash and Equivalents | 1.22B |
| Cash and Equivalents (USD) | 1.22B |
| Investments | 16.30M |
| Investments Non-Current | 16.30M |
| Trade and Non-Trade Receivables | 398.68M |
| Current Assets | 2.31B |
| Property, Plant & Equipment Net | 710.39M |
| Total Assets | 5.83B |
| Total Debt | 1.55B |
| Current Liabilities | 712.76M |
| Debt Non-Current | 1.55B |
| Total Liabilities | 2.48B |
| Accumulated Retained Earnings (Deficit) | 38.79M |
| Accumulated Other Comprehensive Income | 4.06M |
| Shareholders Equity | 3.34B |
| Shareholders Equity (USD) | 3.34B |
| Assets Non-Current | 3.52B |
| Total Debt (USD) | 1.55B |
| Goodwill and Intangible Assets | 2.47B |
| Inventory | 553.72M |
| Liabilities Non-Current | 1.77B |
| Trade and Non-Trade Payables | 242.87M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 62.70M |
| Net Cash Flow from Financing | -392.08M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -99.49M |
| Capital Expenditure | 30.48M |
| Issuance (Purchase) of Equity Shares | -389.65M |
| Net Cash Flow from Investing | 18.13M |
| Net Cash Flow from Operations | 276.26M |
| Effect of Exchange Rate Changes on Cash | -1.82M |
| Share Based Compensation | 26.32M |